Aquestive Therapeutics, Inc. AQST Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s gross profit?
- Aquestive Therapeutics, Inc. (AQST) reported gross profit of $10.98M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s gross profit changed year-over-year?
- Aquestive Therapeutics, Inc.'s gross profit increased by 116.6% year-over-year, from $5.07M to $10.98M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s gross profit?
- Over 3 years (2022 to 2025), Aquestive Therapeutics, Inc.'s gross profit has grown at a -2.8% compound annual growth rate (CAGR), from $28.29M to $25.99M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.